Cannabinoids bond to digit G-protein-coupled receptors, CB1 and CB2, spoken by neurons and cells of the insusceptible system, respectively. Glioma cells (astrocyte-derived mentality growth cells) impart cannabinoid receptors, and numerous in vitro and in vivo studies performed in rodents hit over that necrobiosis could be evoked by cannabinoids in these cells. Whether this also applies to manlike cells is controversial; we, therefore, assessed the gist of cannabinoids on manlike glioma radiophone viability with the manlike astrocytoma radiophone distinction U373MG. We inform here that U373MG manlike glioma cells are huffy exclusive to broad concentrations of cannabinoids (>5 [mu]g/ml for [Delta]9-THC). Similar concentrations of the compounds promoted a fast activation of extracellular-regulated kinase and c-Jun NH2-terminal kinase, suggesting that cannabinoid receptors are useful in U373MG cells. Nevertheless, these kinases are not participating in cannabinoid-induced radiophone modification in U373MG cells, insofar as interference their activation with limited inhibitors does not turn radiophone death. CB1 is spoken in U373MG cells and is participating in cannabinoid-induced radiophone death, in that interference its activation with a limited opposer (AM251) nearly totally prevented radiophone modification mass birth of the cells with [Delta]9-THC. In addition, as already reported, whatever cannabinoids haw hit overmodest proproliferative properties in U373MG cells. Human U373MG glioma cells are huffy exclusive to rattling high, pharmacologically extraneous concentrations of cannabinoids, so it seems implausible that cannabinoids would represent auspicious molecules for treating cancerous astrocytoma; they do not rush glioma radiophone modification at doses that could be practical safely to humans. © 2008 Wiley-Liss, Inc. (Source: Journal of Neuroscience Research)

Tags: apoptosis, Brain, Concentration, glioma, Led, Neuron, Neurons